Herb Buxton, US Geological Survey Toxic Substances Hydrology Program
Presentation
Abstract
Ron Bloom, US FDA Center for Drug Evaluation and Research in Office of Pharmaceutical Science
Presentation
Abstract
Suzanne Rudzinski, US EPA Office of Science and Technology in Office of Water
Presentation
John Sumpter, Brunel University Institute for the Environment
Presentation
Damian Shea, NC State Department of Biology
Presentation
Howard Weinberg, UNC Department of Environmental Sciences and Engineering
Abstract
Mike Williams, NC State Animal Waste Management Programs
Presentation
Abstract
Jim Lazorchak, EPA Molecular Indicator Research Branch
Presentation
Analysis of Ecologically Relevant Pharmaceuticals in Wastewater and Surface Water Using Selective Solid-Phase Extraction and UPLC-MS/MS
Risks to Aquatic Organisms Posed by Human Pharmaceutical Use
Keith Solomon, University of Guelph Centre for Toxicology and Department of Environmental Biology
Presentation
Christian Daughton, US EPA National Exposure Research Laboratory
Presentation
Abstract
Doug Finan, GlaxoSmithKline Environment, Health and Safety Regulatory Affairs
Presentation
Rachel Golden Smith, NC Department of Environment and Natural Resources
Presentation
Resources
Kathleen Gray, UNC Institute for the Environment
Presentation
Mike Newton-Ward, NC Division of Public Health
Presentation
Abstract
EU KNAPPE: Knowledge and Need Assessment on Pharmaceutical Products in Environmental Waters
US EPA “Pharmaceuticals and Personal Care Products (PPCPs): Relevant Literature”
Phamaceuticals in the Environment. PhRMA Briefing Paper: PIE Background
Phamaceuticals in the Environment. PhRMA Briefing Paper: Human Health
Removal of EDCs and Pharmaceuticals in Drinking and Reuse Treatment Processes
Toxicological Relevance of EDCs and Pharmaceuticals in Drinking Water
State of Knowledge of Endocrine Disruptors and Pharmaceuticals in Drinking Water